Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable Growth
GlobeNewswire
· Company expects to achieve $45-$50 million in annualized operating expense savings in fiscal 2025
· Management to discuss..
· Company expects to achieve $45-$50 million in annualized operating expense savings in fiscal 2025
· Management to discuss..
SAN DIEGO, Feb. 28, 2024 (GLOBE NEWSWIRE) -- Bionano Genomics, Inc. (Nasdaq: BNGO) today announced that it will host a conference..
#mediatalk #davidholmes #danielradcliffe